Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?

被引:26
|
作者
Reichman, David E. [1 ]
Chung, Pak [1 ]
Meyer, Laura [1 ]
Greenwood, Eleni [2 ]
Davis, Owen [1 ]
Rosenwaks, Zev [1 ]
机构
[1] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA
[2] Weill Cornell Med Ctr, New York, NY 10021 USA
关键词
IVF; consecutive cycles; time interval; OVARIAN HYPERSTIMULATION SYNDROME; GNRH ANTAGONIST; LUTEAL SUPPORT; STIMULATION; PROTOCOL; AGONIST; TRIGGER;
D O I
10.1016/j.fertnstert.2012.11.044
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether patients who failed an in vitro fertilization (IVF) cycle can proceed with a subsequent IVF cycle after waiting only one menstrual cycle, or whether there is a benefit to allowing two or more menstrual cycles to elapse before proceeding. Design: Retrospective cohort study. Setting: Academic medical center. Patient(s): All patients undergoing IVF cycles at The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, from January 1, 2002 to November 1, 2011, in whom two consecutive gonadotropin-releasing hormone (GnRH)-antagonist IVF cycles with identical stimulation protocols took place 35-140 days apart, excluding patients in whom the first cycle resulted in a clinical pregnancy. Intervention(s): None. Main Outcome Measure(s): IVF outcomes were compared for 164 patients who initiated a cycle after waiting only one menstrual cycle (35-55 days from previous oocyte retrieval) versus 557 patients waiting two or more menstrual cycles (56-140 days) from their last retrieval before proceeding with their successive cycle start, stratifying for age. Result(s): No differences were detected regarding E-2 response, oocyte yield, fertilization, or embryo development when comparing patients waiting only one cycle with those waiting two or more cycles, nor were those parameters different when comparing patients' index cycles with their immediate preceding failed cycles. Moreover, clinical outcomes regarding clinical pregnancy, live birth, and cycle cancellation were similar between both study groups. Conclusion(s): Delaying successive IVF cycle start for two or more menstrual cycles likely offers no advantage over pursuing repeated IVF after one menstrual cycle. (Fertil Steril (R) 2013; 99:1277-82. (C) 2013 by American Society for Reproductive Medicine.)
引用
收藏
页码:1277 / 1282
页数:6
相关论文
共 50 条
  • [11] Antimullerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization
    Hamdine, Ouijdane
    Eijkemans, Marinus J. C.
    Lentjes, Eef G. W.
    Torrance, Helen L.
    Macklon, Nick S.
    Fauser, Bart C. J. M.
    Broekmans, Frank J.
    FERTILITY AND STERILITY, 2015, 104 (04) : 891 - +
  • [12] Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
    Papanikolaou, EG
    Pozzobon, C
    Kolibianakis, EM
    Camus, M
    Tournaye, H
    Fatemi, HM
    Van Steirteghem, A
    Devroey, P
    FERTILITY AND STERILITY, 2006, 85 (01) : 112 - 120
  • [13] Predictors and Implications of Estradiol Rise After Gonadotropin-Releasing Hormone Antagonist Initiation During in Vitro Fertilization Cycles
    Scotchie, Jessica G.
    Will, Matthew
    Fritz, Marc A.
    Steiner, Anne Z.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2009, 54 (04) : 211 - 217
  • [14] Combined Administration of Gonadotropin-releasing Hormone Agonist with Human Chorionic Gonadotropin for Finall Oocyte Maturation in GnRH Antagonist Cycles for in Vitro Fertilization
    Kim, Chung-Hoon
    Ahn, Jun-Woo
    You, Rae-Mi
    Kim, Sung-Hoon
    Chae, Hee-Dong
    Kang, Byung-Moon
    JOURNAL OF REPRODUCTIVE MEDICINE, 2014, 59 (1-2) : 63 - 68
  • [15] Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization-embryo transfer cycles
    Younis, Johnny S.
    Soltsman, Sofia
    Izhaki, Ido
    Radin, Orit
    Bar-Ami, Shalom
    Ben-Ami, Moshe
    FERTILITY AND STERILITY, 2010, 94 (04) : 1350 - 1355
  • [16] Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization
    Mohamed, KA
    Davies, WAR
    Lashen, H
    GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (02) : 57 - 62
  • [17] The effect of delayed initiation of gonadotropin-releasing hormone antagonist in a flexible protocol on in vitro fertilization outcome
    Tannus, Samer
    Weissman, Ariel
    Boaz, Mona
    Horowitz, Eran
    Ravhon, Amir
    Golan, Abraham
    Levran, David
    FERTILITY AND STERILITY, 2013, 99 (03) : 725 - 730
  • [18] Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist
    Williams, SC
    Gibbons, WE
    Muasher, SJ
    Oehninger, S
    FERTILITY AND STERILITY, 2002, 78 (05) : 1068 - 1072
  • [19] The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis
    Xiao, Jinsong
    Chang, Shuang
    Chen, Shuangyun
    FERTILITY AND STERILITY, 2013, 100 (06) : 1594 - +
  • [20] Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes
    Weitzman, Vanessa N.
    Engmann, Lawrence
    DiLuigi, Andrea
    Maier, Donald
    Nulsen, John
    Benadiva, Claudio
    FERTILITY AND STERILITY, 2009, 92 (01) : 226 - 230